Mercer Global Advisors Inc Lyell Immunopharma, Inc. Transaction History
Mercer Global Advisors Inc
- $39.5 Billion
- Q2 2024
A detailed history of Mercer Global Advisors Inc transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 40,397 shares of LYEL stock, worth $51,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,397
Previous 42,792
5.6%
Holding current value
$51,708
Previous $95,000
38.95%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LYEL
# of Institutions
123Shares Held
145MCall Options Held
2.6KPut Options Held
7.5K-
Mwg Management Ltd. Washington, DC20.2MShares$25.8 Million31.93% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$19.3 Million16.63% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$19.3 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$17.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$17.1 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $317M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...